Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers

Current Opinion in Oncology

Volumn 13, Issue 3, 2001, Pages 183-188

  Gillison, Maura L ^a   Shah, Keerti V ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER RISK; DISEASE ASSOCIATION; HEAD CANCER; HIGH RISK POPULATION; HUMAN; NECK CANCER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TONSIL CANCER;

ADULT; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 0035031174     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200105000-00009     Document Type: Review

References (40)

1. 1 Loning T, Ikenberg H, Becker J, et al.: Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 1985, 84:417-420.
2. 2 Gillison M, Koch W, Shah K: Human papillomavirus and head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 1999, 11:191-199.
3. 3 Hill A: The environment and disease; association or causation. Proc R Soc Med 1965, 58:295-300.
4. 4 zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92:690-698.
5. 5 zur Hausen H: Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 1999, 9:405-411.
6. 6 International Agency for Research on Cancer: Monograph on the Evaluation of Carcinogenic Risks to Humans, Volume 64. Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer; 1995.
7. 7 Walboomers J, Jacobs M, Manos M, et al.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
8. 8 Koch W, Lango M, Sewell D, et al.: Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999, 109:1544-1551.
9. 9 Gillison M, Koch W, Capone R, et al.: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720. Building on findings from epidemiologic and molecular studies that preceded it, this paper provides very strong evidence that HPV-positive oropharyngeal cancers comprise a distinct molecular, clinical, and pathologic disease entity that is causally associated with HPV infection. HPV positivity significantly improved disease-free survival.
10. 10 Capone R, Pai S, Koch W, et al.: Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000, 6:4171-4175.
11. 11 Tseng C, Pao C, Lin J, et al.: Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis, J Clin Oncol 1999, 17:1391-1396.
12. 12 Meschede W, Zumbach K, Braspenning J, et al.: Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998, 36:475-480.
13. 13 Sun Y, Eluf-Neto J, Bosch F, et al.: Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma. Cancer Epidemiol Biomarkers Prev 1999, 8:935-940.
14. 14 Zumbach K, Hoffman M, Kahn T, et al.: Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer 2000, 85:815-818.
15. 15 Mellin H, Friesland S, Lewensohn R, et al.: Human papillomavirus (HPV) DNA in tonsiliar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000, 89:300-304. This study supports the hypothesis that the improved prognosis observed for HPV-positive HNSCC may result from enhanced radiation sensitivity.
16. 16 Sisk E, Bradford C, Jacob A, et al.: Human papillomavirus infection in "young" versus "old" patients with squamous cell carcinoma of the head and neck. Head Neck 2000, 22:649-657.
17. 17 Pintos J, Franco E, Black M, et al.: Human papillomavirus and prognosis of patients with cancers of the upper aerodigestive tract. Cancer 1999, 85:1903-1909.
18. 18 Badaracco G, Venuti A, Morello R, et al.: Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 2000, 20:1301-1306.
19. 19 Romanczuk H, Thierry F, Howley P: Mutational analysis of cis elements involved in modulation of human papillomavirus type 16 p97 and type 18 p105 promoters. J Virol 1990, 64:2849-2859.
20. 20 Venuti A, Manni V, Morello R, et al.: Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000, 60:396-402.
21. 21 Dao Ke L, Adler-Storthz K, Follen Mitchell M, et al.: Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol 1999, 35:415-420.
22. 22 Brennan J, Mao L, Hruban R, et al.: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995, 332:429-435.
23. 23 Nishioka S, Fukushima K, Nishizaki K, et al.: Human papillomavirus as a risk factor for head and neck cancers: a case-control study. Acta Otolaryngol Suppl (Stockh) 1999, 540:77-80.
24. 24 Tsuhako K, Nakazato I, Miyagi J, et al.: Comparative study of oral squamous cell carcinoma in Okinawa, Southern Japan and Sapporo in Hokkaido, Northern Japan; with special reference to human papillomavirus and Epstein-Barr virus infection. J Oral Pathol Med 2000, 29:70-79.
25. 25 Saranath D, Tandle A, Teni T, et al.: p53 inactivation in chewing tobacco-induced oral cancers and leukopiakias from India. Oral Oncol 1999, 35:242-250.
26. 26 Temam S, Flahault A, Perie S, et al.: p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. J Clin Oncol 2000, 18:385-394.
27. 27 Niv A, Sion-Vardi N, Gatot A, et al.: Identification and typing of human papillomavirus (HPV) in squamous cell carcinomas of the oral cavity and oropharynx. J Laryngol Otol 2000, 114:41-46.
28. 28 Ganly I, Soutar D, Kaye S: p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy. Br J Cancer 2000, 82:392-398.
29. 29 Punwaney R, Brandwein M, Zhang D, et al.: Human papillomavirus may be common within nasopharyngeal carcinoma of caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck 1999, 21:21-29.
30. 30 Frisch M, Hjalgrim H, Jaeger A, et al.: Changing patterns of tonsiliar squamous cell carcinoma in the United States. Cancer Causes Control 2000, 11:489-495. Tonsiliar cancer incidence rates are evaluated separately from other oral cavity cancers in this paper. Incidence rates are increasing despite declines in tobacco use, suggesting increasing exposure to other carcinogens. The author hypothesizes that this finding may be because of HPV.
31. 31 Frisch M, Biggar R: Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999, 354:1442-1443. Patients with HPV-associated malignancies are at increased risk for tonsillar carcinoma, suggesting a common etiology.
32. 32 Frisch M, Biggar R, Goedert J: Human papillomavirus-associated cancers in patients with human immunodeficiency syndrome. J Natl Cancer Inst 2000, 92:1500-1510. This important paper provides evidence that risk of HPV-associated in situ carcis nomas increases as CD-4 counts decline in HIV-infected individuals. This paper is the first to report an increased risk for tonsillar carcinoma in immunosuppressed individuals.
33. 33 Swoboda A, Fabrizii V: Tonsillar carcinoma in a renal graft recipient treated with cyclosporine. Clin Nephrol 1993, 39:272-274.
34. 34 Demetrick D, Inoue M, Lester W, et al.: Human papillomavirus type 16 associated with oral squamous cell carcinoma in a cardiac transplant recipient. Cancer 1990, 66:1726-1731.
35. 35 Echert L, Watts D, Koutsky L, et al.: A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy. Infect Dis Obstet Gynecol 1999, 7:158-164.
36. 36 Ahdieh L, Munoz A, Vlahov D, et al.: Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 2000, 151:1148-1157.
37. 37 Resnick R, Conrelisen M, Wright D, et al.: Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990, 82:1477-1484.
38. 38 Pillai M, Phanidhara A, Kesari A, et al: Cellular manifestations of human papillomavirus infection in the oral mucosa. J Surg Oncol 1999, 71:10-15.
39. 39 Sand L, Jalouli J, Larsson P, et al.: Human papilloma viruses in oral lesions. Anticancer Res 2000, 20:1183-1188.
40. 40 Bouda A, Gorgoulis V, Kastrinakis N, et al.: "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal controls, Mod Pathol 2000, 13:644-653.